INS and polycystic ovary syndrome: Increased fasting insulin level and impaired IR, as determined by HOMA-IR in the letrozole-treated PCOS rats (Figures 2F–I), indicated abnormal endocrine and metabolic changes, although the areas under curve (AUC) of glucose concentration were comparable between groups.